vs
Side-by-side financial comparison of IMAX CORP (IMAX) and PROCEPT BioRobotics Corp (PRCT). Click either name above to swap in a different company.
IMAX CORP is the larger business by last-quarter revenue ($125.2M vs $83.1M, roughly 1.5× PROCEPT BioRobotics Corp). IMAX CORP runs the higher net margin — 0.5% vs -38.1%, a 38.6% gap on every dollar of revenue. On growth, IMAX CORP posted the faster year-over-year revenue change (35.1% vs 20.2%). Over the past eight quarters, IMAX CORP's revenue compounded faster (25.8% CAGR vs 24.8%).
IMAX Corporation is a Canadian production theatre company which designs and manufactures IMAX cameras and projection systems as well as performing film development, production, post-production and distribution to IMAX-affiliated theatres worldwide. Founded in Montreal in 1967, it has headquarters in the Toronto area, and operations in New York City and Los Angeles.
PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.
IMAX vs PRCT — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $125.2M | $83.1M |
| Net Profit | $637.0K | $-31.6M |
| Gross Margin | 57.6% | 64.9% |
| Operating Margin | 19.3% | -4.1% |
| Net Margin | 0.5% | -38.1% |
| Revenue YoY | 35.1% | 20.2% |
| Net Profit YoY | -88.0% | -27.9% |
| EPS (diluted) | $0.02 | $-0.56 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $83.1M | ||
| Q4 25 | $125.2M | $76.4M | ||
| Q3 25 | $106.7M | $83.3M | ||
| Q2 25 | $91.7M | $79.2M | ||
| Q1 25 | $86.7M | $69.2M | ||
| Q4 24 | $92.7M | $68.2M | ||
| Q3 24 | $91.5M | $58.4M | ||
| Q2 24 | $89.0M | $53.4M |
| Q1 26 | — | $-31.6M | ||
| Q4 25 | $637.0K | $-29.8M | ||
| Q3 25 | $20.7M | $-21.4M | ||
| Q2 25 | $11.3M | $-19.6M | ||
| Q1 25 | $2.3M | $-24.7M | ||
| Q4 24 | $5.3M | $-18.9M | ||
| Q3 24 | $13.9M | $-21.0M | ||
| Q2 24 | $3.6M | $-25.6M |
| Q1 26 | — | 64.9% | ||
| Q4 25 | 57.6% | 60.6% | ||
| Q3 25 | 63.1% | 64.8% | ||
| Q2 25 | 58.5% | 65.4% | ||
| Q1 25 | 61.4% | 63.9% | ||
| Q4 24 | 52.2% | 64.0% | ||
| Q3 24 | 55.8% | 63.2% | ||
| Q2 24 | 49.4% | 59.0% |
| Q1 26 | — | -4.1% | ||
| Q4 25 | 19.3% | -40.6% | ||
| Q3 25 | 27.2% | -27.8% | ||
| Q2 25 | 15.6% | -28.0% | ||
| Q1 25 | 19.3% | -39.7% | ||
| Q4 24 | 10.3% | -28.9% | ||
| Q3 24 | 21.2% | -38.4% | ||
| Q2 24 | 3.2% | -50.3% |
| Q1 26 | — | -38.1% | ||
| Q4 25 | 0.5% | -39.1% | ||
| Q3 25 | 19.4% | -25.7% | ||
| Q2 25 | 12.3% | -24.7% | ||
| Q1 25 | 2.7% | -35.8% | ||
| Q4 24 | 5.7% | -27.6% | ||
| Q3 24 | 15.2% | -35.9% | ||
| Q2 24 | 4.0% | -48.0% |
| Q1 26 | — | $-0.56 | ||
| Q4 25 | $0.02 | $-0.54 | ||
| Q3 25 | $0.37 | $-0.38 | ||
| Q2 25 | $0.20 | $-0.35 | ||
| Q1 25 | $0.04 | $-0.45 | ||
| Q4 24 | $0.09 | $-0.34 | ||
| Q3 24 | $0.26 | $-0.40 | ||
| Q2 24 | $0.07 | $-0.50 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $151.2M | $245.6M |
| Total DebtLower is stronger | — | $51.7M |
| Stockholders' EquityBook value | $337.9M | $347.7M |
| Total Assets | $894.0M | $487.1M |
| Debt / EquityLower = less leverage | — | 0.15× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $245.6M | ||
| Q4 25 | $151.2M | $286.5M | ||
| Q3 25 | $143.1M | $294.3M | ||
| Q2 25 | $109.3M | $302.7M | ||
| Q1 25 | $97.1M | $316.2M | ||
| Q4 24 | $100.6M | $333.7M | ||
| Q3 24 | $104.5M | $196.8M | ||
| Q2 24 | $91.6M | $214.1M |
| Q1 26 | — | $51.7M | ||
| Q4 25 | — | $51.6M | ||
| Q3 25 | — | $51.6M | ||
| Q2 25 | — | $51.5M | ||
| Q1 25 | — | $51.5M | ||
| Q4 24 | — | $51.5M | ||
| Q3 24 | — | $51.4M | ||
| Q2 24 | — | $51.4M |
| Q1 26 | — | $347.7M | ||
| Q4 25 | $337.9M | $365.9M | ||
| Q3 25 | $349.5M | $380.3M | ||
| Q2 25 | $320.4M | $385.8M | ||
| Q1 25 | $299.5M | $389.2M | ||
| Q4 24 | $299.5M | $402.2M | ||
| Q3 24 | $289.4M | $241.2M | ||
| Q2 24 | $267.2M | $251.8M |
| Q1 26 | — | $487.1M | ||
| Q4 25 | $894.0M | $508.1M | ||
| Q3 25 | $889.6M | $511.5M | ||
| Q2 25 | $868.6M | $513.1M | ||
| Q1 25 | $848.3M | $519.4M | ||
| Q4 24 | $830.4M | $534.0M | ||
| Q3 24 | $847.6M | $374.1M | ||
| Q2 24 | $827.4M | $374.4M |
| Q1 26 | — | 0.15× | ||
| Q4 25 | — | 0.14× | ||
| Q3 25 | — | 0.14× | ||
| Q2 25 | — | 0.13× | ||
| Q1 25 | — | 0.13× | ||
| Q4 24 | — | 0.13× | ||
| Q3 24 | — | 0.21× | ||
| Q2 24 | — | 0.20× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $29.4M | — |
| Free Cash FlowOCF − Capex | $28.0M | — |
| FCF MarginFCF / Revenue | 22.3% | — |
| Capex IntensityCapex / Revenue | 1.1% | — |
| Cash ConversionOCF / Net Profit | 46.11× | — |
| TTM Free Cash FlowTrailing 4 quarters | $118.9M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $29.4M | $-10.3M | ||
| Q3 25 | $67.5M | $-6.6M | ||
| Q2 25 | $23.2M | $-15.0M | ||
| Q1 25 | $7.0M | $-17.0M | ||
| Q4 24 | $11.5M | $-32.4M | ||
| Q3 24 | $35.3M | $-18.8M | ||
| Q2 24 | $35.0M | $-15.7M |
| Q1 26 | — | — | ||
| Q4 25 | $28.0M | $-12.2M | ||
| Q3 25 | $64.8M | $-9.5M | ||
| Q2 25 | $20.9M | $-17.8M | ||
| Q1 25 | $5.3M | $-18.8M | ||
| Q4 24 | $6.9M | $-33.6M | ||
| Q3 24 | $34.2M | $-19.0M | ||
| Q2 24 | $33.5M | $-16.8M |
| Q1 26 | — | — | ||
| Q4 25 | 22.3% | -15.9% | ||
| Q3 25 | 60.7% | -11.4% | ||
| Q2 25 | 22.8% | -22.5% | ||
| Q1 25 | 6.1% | -27.2% | ||
| Q4 24 | 7.4% | -49.2% | ||
| Q3 24 | 37.3% | -32.6% | ||
| Q2 24 | 37.6% | -31.4% |
| Q1 26 | — | — | ||
| Q4 25 | 1.1% | 2.4% | ||
| Q3 25 | 2.6% | 3.4% | ||
| Q2 25 | 2.6% | 3.5% | ||
| Q1 25 | 1.9% | 2.7% | ||
| Q4 24 | 5.0% | 1.7% | ||
| Q3 24 | 1.2% | 0.4% | ||
| Q2 24 | 1.8% | 2.0% |
| Q1 26 | — | — | ||
| Q4 25 | 46.11× | — | ||
| Q3 25 | 3.27× | — | ||
| Q2 25 | 2.06× | — | ||
| Q1 25 | 2.99× | — | ||
| Q4 24 | 2.16× | — | ||
| Q3 24 | 2.54× | — | ||
| Q2 24 | 9.78× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
IMAX
| Technology Sales | $46.6M | 37% |
| Image Enhancement And Maintenance Services | $38.1M | 30% |
| Joint Revenue Sharing Arrangement | $20.4M | 16% |
| Maintenance | $16.3M | 13% |
| Finance Income | $2.8M | 2% |
| Other Content Solutions | $1.6M | 1% |
PRCT
| Handpieces and other consumables | $43.0M | 52% |
| System sales and rentals | $23.4M | 28% |
| Other | $11.1M | 13% |
| Service | $5.6M | 7% |
